Sen. Tillis cleared to resume in-person activities 10 days after coronavirus diagnosis

North Carolina news

RALEIGH, N.C. (WNCN) – Sen. Thom Tillis (R-NC) was cleared to resume in-person activities 10 days after testing positive for the coronavirus, according to a release from his office.

Tillis’ personal physician released a letter giving the senator, who is up for reelection in November, clearance to end his quarantine and resume in-person activities. The decision was made per Centers for Disease Control guidelines, Dr. Jack Faircloth said.

You can read Faircloth’s full letter here.

Tillis first tested positive for the virus on Oct. 2. The senator originally said he was experiencing no symptoms but soon after said he had “mild symptoms,” but his condition did not decline any further and by Oct. 5 he said he was no longer experiencing any symptoms at all.

In addition to getting clearance to resume in-person activities, Tillis also announced that he will be taking part in an antibody study in partnership with Atrium Health and Wake Forest Baptist Health. He is also planning to participate in a study by UNC-Chapel Hill that is considered “the nation’s largest coordinated effort to study immunology and COVID-19 in the United States,” the release said.

Tillis released the following statement:

I want to thank my doctors who provided guidance throughout my quarantine since testing positive for COVID-19. I feel very fortunate that I had a mild case with few symptoms, and I want to thank North Carolinians for their prayers and well-wishes. As we all know, COVID-19 is a very contagious and deadly virus, and I am proud to enroll in the antibody research study through Atrium Health and Wake Forest Baptist Health and volunteer to participate in UNC Chapel Hill’s immunology study and help however I can to end COVID. I look forward to returning to Washington and participating in-person at the Senate Judiciary hearings and confirm Judge Amy Coney Barrett to the Supreme Court.”

More headlines from

Copyright 2021 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Stories

Click here for full list of trending stories